Speaker illustration

Mr Sake van der Wall

Spaarne Gasthuis, Haarlem (Netherlands (The))

Member of:

European Society of Cardiology
European Association of Cardiovascular Imaging
European Heart Rythm Association

Evaluation of appropriate use and clinical outcomes of idarucizumab as antidote of dabigatran in daily clinical practice

Event: ESC Congress 2018

Topic: Oral Anticoagulation

Session: Atrial fibrillation - Stroke prevention

Thumbnail